Levetiracetam Sandoz

Levetiracetam, the active ingredient in Levetiracetam Sandoz, is an anticonvulsant presented as a tablet for oral use. It is prescribed to manage partial‑onset, myoclonic, and generalized tonic‑clonic seizures in patients with epilepsy, helping to reduce seizure frequency and improve neurological stability.

GNH USA supplies Levetiracetam Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to essential antiepileptic medication for healthcare providers across multiple regions, including both public and private sector institutions and research centers.

Levetiracetam is an anticonvulsant used to treat seizure disorders.

- Partial‑onset seizures: reduces the frequency of focal seizures. - Myoclonic seizures: decreases occurrence of sudden muscle jerks. - Generalized tonic‑clonic seizures: helps prevent full‑body convulsive episodes.

Levetiracetam may cause a range of adverse reactions.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Headache: mild to moderate head pain. - Irritability: mood changes or agitation. - Nausea: upset stomach or feeling of queasiness. - Fatigue: general lack of energy.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or difficulty breathing. - Mood alterations: depression, anxiety, or suicidal thoughts. - Stevens‑Johnson syndrome: rare severe skin reaction. - Blood dyscrasias: low white blood cells or platelets. - Hepatic injury: abnormal liver function tests. - Respiratory depression: marked breathing difficulty when combined with other CNS depressants.

Before prescribing Levetiracetam, clinicians should consider several safety factors.

- Renal function: assess baseline and monitor, dose may need adjustment in impairment. - Hepatic function: evaluate liver status, especially in patients with existing disease. - Psychiatric history: watch for mood changes, depression, or suicidal ideation. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy and lactation: evaluate risk‑benefit; limited data are available. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Levetiracetam can interact with other medicines, requiring attention to potential changes in efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenytoin: can reduce levetiracetam effectiveness. - Phenobarbital: may decrease levetiracetam levels.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance central nervous system depression. - Other antiepileptics: dose adjustments may be necessary. - Renal excretion inhibitors (e.g., probenecid): may increase levetiracetam exposure.